Source:http://linkedlifedata.com/resource/pubmed/id/11409557
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-6-18
|
pubmed:abstractText |
Twenty-seven consecutive patients at high risk of developing heterotopic ossifications (HO) after implantation of a hydroxyapatite (HA)-coated hip prosthesis were irradiated with a single dose of 7 Gy, at least 4 h before the operation. The femoral stem was not shielded during radiotherapy (RT). After a median follow-up of 14.8 months, no clinically significant HO could be found, while 12 (52%) patients in this high-risk population had only minor HO (grade I). No reoperation was needed, and no evidence of prosthesis migration was observed. We conclude that single-dose, preoperative RT for HA-coated hip prosthesis can effectively inhibit HO. Not blocking the femoral stem does not result in prosthesis migration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0936-8051
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
121
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
271-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11409557-Adult,
pubmed-meshheading:11409557-Aged,
pubmed-meshheading:11409557-Aged, 80 and over,
pubmed-meshheading:11409557-Arthroplasty, Replacement, Hip,
pubmed-meshheading:11409557-Coated Materials, Biocompatible,
pubmed-meshheading:11409557-Durapatite,
pubmed-meshheading:11409557-Female,
pubmed-meshheading:11409557-Hip Prosthesis,
pubmed-meshheading:11409557-Humans,
pubmed-meshheading:11409557-Male,
pubmed-meshheading:11409557-Middle Aged,
pubmed-meshheading:11409557-Ossification, Heterotopic,
pubmed-meshheading:11409557-Preoperative Care,
pubmed-meshheading:11409557-Prosthesis Design,
pubmed-meshheading:11409557-Radiotherapy Dosage
|
pubmed:year |
2001
|
pubmed:articleTitle |
Preoperative radiotherapy without femoral shielding for prevention of heterotopic ossification in hydroxyapatite-coated hip prostheses.
|
pubmed:affiliation |
Department of Radiotherapy, Triemli Hospital, Zürich, Switzerland. dantaussky@hotmail.com
|
pubmed:publicationType |
Journal Article
|